MDT - Medtronic plc
Close
81.68
0.230 0.282%
Share volume: 13,754
Last Updated: Thu 26 Dec 2024 04:30:08 PM CET
Surgical and Medical Instrument Manufacturing :
1.37%
PREVIOUS CLOSE
CHG
CHG%
$81.45
0.23
0.28%
Fundamental analysis
56%
Profitability
42%
Dept financing
46%
Liquidity
26%
Performance
80%
Performance
5 Days
0.63%
1 Month
-4.91%
3 Months
-8.78%
6 Months
1.41%
1 Year
-0.46%
2 Year
5.02%
Key data
Stock price
$81.68
DAY RANGE
$81.29 - $81.62
52 WEEK RANGE
$76.99 - $92.68
52 WEEK CHANGE
-$1.07
DIVIDEND
$0.70
EX-DIVIDEND DATE
06/28/2024
NEXT EARNINGS DATE
11/19/2024
Company detail
CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.
Recent news